Invention Grant
US08476239B2 Stable protein formulations 有权
稳定的蛋白质配方

Stable protein formulations
Abstract:
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
Public/Granted literature
Information query
Patent Agency Ranking
0/0